Illinois Supreme Court Severs Non-Party Arbitration in Geller v. Uber
The Illinois Supreme Court decided Geller v. Uber Technologies, et al., Case No. 132066, on September 24, 2026, holding that Gloria Sheridan Geller's wrongful-death action over her husband Mark Geller's fatal April 2022 crash near Midway Airport cannot be compelled to arbitration under the Uber account Mark had signed. The agreement bound Mark as a contracting party; it did not bind Gloria, a non-party survivor pressing a statutory wrongful-death claim. Clifford Law Offices partner Charles R. Haskins argued and won for the Geller estate.
The ruling carries immediate persuasive weight in every jurisdiction where rideshare defendants have moved to enforce consumer arbitration clauses against surviving family members. TNC defense counsel will attempt to distinguish Geller on state-law grounds, but plaintiff bar in California, Texas, and Florida now holds a high-court appellate hook to oppose arbitration in comparable wrongful-death postures, specifically the motion-to-compel directed at a non-signing family member that defense counsel deploy most frequently in TNC wrongful-death litigation.
For medical providers holding letters of protection on TNC-injury files, open court litigation in Uber and Lyft wrongful-death cases produces more trackable docket schedules and, typically, larger public verdict benchmarks than the confidential, delayed timelines arbitration generates.
Bar takeaway: Immediately audit every pending TNC wrongful-death file where defendant has moved to compel arbitration; Geller is the strongest non-party counterargument in the country as of this week.
New York CPLR 1411(b): The 50-Percent Fault Bar Takes Effect in Auto Cases
New York CPLR §1411(b), signed by Governor Hochul as part of the FY2027 state budget and effective May 26, 2026, bars any motor-vehicle plaintiff found more than 50 percent at fault from recovering pain-and-suffering damages. Pure comparative negligence survives for premises, products, and professional-negligence claims under §1411(a). The plaintiff bar has called the auto provision the most significant New York tort shift since the 1973 no-fault law. The legislature simultaneously eliminated the 90/180-day serious-injury threshold from Insurance Law §5102(d).
The practical effect is sharpest in Manhattan, Kings County, and Queens. A plaintiff documented at 51 percent fault walks away with zero non-economic recovery regardless of injury severity, and defense counsel will price that exposure floor into initial offers. Cases where liability allocation is contested near the midpoint now require earlier expert-liability retention and updated intake questionnaires before any demand is issued.
The §5102(d) deletion removes a historically plaintiff-favorable serious-injury tier. Cases premised primarily on 90-plus days of disability, a common posture in soft-tissue representations, no longer qualify under that subcategory and must satisfy a different threshold or face summary dismissal.
Bar takeaway: For all New York auto cases filed after May 26, 2026, build fault-allocation analysis into intake before issuing any demand, and retire the 90/180-day threshold as a standalone serious-injury theory.
K.G.M. v. Meta: $6 Million Verdict Opens Product-Liability Door on Social Media
The Los Angeles Superior Court jury in K.G.M. v. Meta Platforms, Inc. and Google LLC, tried before Judge Carolyn B. Kuhl, returned a $6 million verdict in March 2026: $3 million compensatory, $3 million punitive. The jury apportioned fault 70 percent to Meta and 30 percent to Google, producing the first U.S. jury finding of product liability against a social-media platform. Snap Inc. and TikTok/ByteDance each settled their positions on January 22 and January 27, 2026, on undisclosed terms before the February 10 trial date; Mark Zuckerberg testified February 18.
Federal MDL 3047, pending before Judge Yvonne Gonzalez Rogers in the Northern District of California, carries 3,208 individual plaintiffs with school-district bellwether trials scheduled for late 2026. The K.G.M. verdict gives MDL plaintiffs a punitive-damages anchor and a documented fault-split framework; defendants will argue state-law product-liability standards differ by jurisdiction, but the threshold liability finding removes the credibility hurdle for subsequent panels.
Bar takeaway: Firms holding individual social-media injury claims should evaluate consolidation into MDL 3047 before late-2026 school-district bellwether results establish a second-generation damages baseline.
California Supreme Court Closes the Duty-to-Innovate Theory in Gilead Tenofovir Cases
A 6-1 California Supreme Court majority, authored by Justice Groban with Justice Evans dissenting, held August 4, 2026 that a pharmaceutical manufacturer owes no duty of care to current users of a non-defective drug when deciding whether or when to commercialize a safer alternative formulation. The ruling eliminated approximately 23,000 consolidated California TDF/HIV drug-injury cases. Orrick represented Gilead Sciences.
The majority drew the duty line at commercialization: a drug meeting FDA standards at time of sale is not rendered defective by the manufacturer's subsequent development or delayed release of an improved compound. Plaintiff counsel had argued that Gilead's documented internal development of a safer tenofovir formulation, combined with its decision to delay commercial launch, constituted actionable failure. The court rejected that theory as a matter of California tort law, finding it would impose an unprecedented ongoing duty to accelerate clinical commercialization decisions.
Plaintiffs pursuing 'delayed-safer-alternative' theories in other states should track the Evans dissent, which provides a ready analytical framework for jurisdictions applying broader duty standards.
Bar takeaway: The Gilead ruling forecloses 'duty-to-innovate' claims in California but leaves conventional design-defect and failure-to-warn theories intact where the original product itself was defective at time of sale.
Illinois Talc Verdict Survives Appeal; Fee-Split Benchmark Set in Chong v. Mardirossian
An Illinois Appellate Court split panel declined in July 2026 to disturb a $45 million talc/mesothelioma verdict against Johnson and Johnson, affirming both wrongful-death and shortened-life damages. The company faces approximately 69,000 claims in federal talc MDL-2738 as of mid-2026. The Illinois decision adds the state to the short list of jurisdictions that have sustained verdicts of that magnitude through post-trial appellate review, a data point that directly affects settlement-value modeling across the MDL pool.
The California Court of Appeal, Second District, decided Chong v. Mardirossian Akaragian LLP, Case No. B341157, on January 8, 2026. Client Christopher Chong voluntarily ratified his firm's unauthorized $6,015,000 personal-injury settlement of a 2016 car-versus-parked-car crash on the 134 Freeway. That ratification entitled the firm to its full 40-to-45 percent contingency of $2,706,750, plus prejudgment interest. After $3,284,151 in combined liens and attorney fees, Chong netted approximately $2,149,000.
Combined provider and attorney obligations consumed more than 54 percent of the gross settlement. Medical providers holding letters of protection on high-fee-ratio files should confirm lien-preservation steps are complete before settlement conferences, because post-ratification shortfall disputes play out exactly as the Chong record illustrates.
Bar takeaway: Document client authorization at every settlement stage; voluntary ratification cures an unauthorized settlement but will not preempt a fee-and-lien dispute that reaches appellate review.
Operations Corner: What This Week's Rulings Mean for Lien Holders
Two of this week's decisions pull lien-recovery economics in opposite directions. New York's §1411(b) lowers the expected-recovery floor on any auto case where comparative fault is contested. A plaintiff reduced to zero pain-and-suffering recovery by the 50-percent bar carries a drastically smaller gross settlement from which provider obligations must be paid. Providers writing letters of protection on post-May-26 New York auto files should build fault-assessment checkpoints into intake, or coordinate with referring counsel on early liability evaluations before authorizing substantial treatment.
Geller v. Uber cuts the other direction. Rideshare wrongful-death cases migrating from private arbitration to open court litigation become longer and more document-intensive, but they typically produce larger verdicts and a transparent resolution record. Providers should log case numbers and assigned-court information at intake on TNC files rather than relying on periodic attorney status updates.
The open question going into Q4 2026 is whether state legislatures in other high-volume auto dockets will follow New York's modified-comparative model, or whether the plaintiff bar's developing due-process challenge to §1411(b) reaches a court willing to enjoin enforcement before the statute generates its first summary-judgment dismissals under the new fault threshold.
Bar takeaway: Providers and firms operating across New York and Illinois need jurisdiction-specific lien protocols before year-end; Geller and §1411(b) push recoverable amounts in opposite directions on TNC and auto files, and no single intake template addresses both.